Tritiated thymidine and bromodeoxyuridine double-labelling studies on growth factors and oral epithelial proliferation in the mouse

Arch Oral Biol. 1999 Sep;44(9):721-34. doi: 10.1016/s0003-9969(99)00066-7.

Abstract

Mouse tongue epithelium is characterized by a circadian variation in the number of cells undergoing DNA synthesis. Groups of male BDF1 mice were followed over 48 h and a double-labelling method with tritiated thymidine and bromodeoxyuridine used to determine S-phase labelling indices, together with cell influx to and cell efflux from S, at 4-hourly time points. Control animals exhibited diurnal peaks in labelling index at 03:00 with trough activity 12 h later at 15:00. Cell influx peaked at 23:00 with troughs occurring between 11:00 to 15:00. Peak cell efflux occurred at 07:00 with trough activity at 19:00. Animals injected with epidermal growth factor at 05:00 demonstrated a significant fall in both influx and efflux throughout the 48-h period (P < 0.001), but with preservation of labelling indices, suggesting a slower transit of cells through S-phase, whereas epidermal growth factor injected at 15:00 only produced a significant rise in cell-efflux values. Adrenergic stimulation by intravenous phenylephrine/isoprenaline injection at both 05:00 and 15:00 resulted in a significant rise in cell efflux (P < 0.001), although there was also a rise in labelling index in the 15:00 group (P < 0.001). Animals injected with calmodulin at 05:00 demonstrated a significant reduction in labelling index throughout the 48-h period (P < 0.001), but maintained control values for cell influx and efflux, suggesting faster transit of cells through S. Calmodulin injection at 15:00 produced only a significant reduction in cell influx (P < 0.001). Administration of exogenous growth factors significantly alters the normal rhythmical proliferation of oral epithelial cells in a mouse model. These effects appear to be both growth factor- and time-dependent, and may have both physiological and pathological implications.

MeSH terms

  • Adrenergic alpha-Agonists / administration & dosage
  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic beta-Agonists / administration & dosage
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Antimetabolites
  • Bromodeoxyuridine
  • Calmodulin / administration & dosage
  • Calmodulin / pharmacology
  • Cell Division / drug effects
  • Circadian Rhythm
  • Disease Models, Animal
  • Epidermal Growth Factor / pharmacology
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Growth Substances / pharmacology*
  • Injections, Intravenous
  • Isoproterenol / administration & dosage
  • Isoproterenol / pharmacology
  • Male
  • Mice
  • Mice, Inbred Strains
  • Mouth Mucosa / cytology
  • Mouth Mucosa / drug effects*
  • Phenylephrine / administration & dosage
  • Phenylephrine / pharmacology
  • Radiopharmaceuticals
  • S Phase / drug effects
  • Thymidine
  • Tritium

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-Agonists
  • Antimetabolites
  • Calmodulin
  • Growth Substances
  • Radiopharmaceuticals
  • Tritium
  • Phenylephrine
  • Epidermal Growth Factor
  • Bromodeoxyuridine
  • Isoproterenol
  • Thymidine